Corporate/M&A

The Debrief: March 2025

In The Debrief, our Practice Leaders across CEE share updates on recent and upcoming legislation, consider the impact of recent court decisions, showcase landmark projects, and keep our readers apprised of the latest developments impacting their respective practice areas.

Zepos & Yannopoulos Advises Kersia Group on Acquisition of Majority Stake in Ikochimiki

Zepos & Yannopoulos has advised France-based Kersia Group on its acquisition of a majority stake in Greece-based Ikochimiki.

Schoenherr Advises on Sale of MyBestPharm to Urgo Healthcare

Schoenherr has advised the shareholder of MyBestPharm on the sale to Laboratoires Urgo Healthcare. DLA Piper reportedly advised the buyers.

Sorainen Advises SafePAS on EUR 700,000 Investment Round for Portable Drug Detection Technology

Sorainen has advised SafePAS on a EUR 700,000 investment round that saw the participation of Securetec Detektions-Systeme, the Estonian Business Angels Network, PurposeTech, BSV Ventures, and the Beamline Accelerator.

Wolf Theiss Advises Vestas on Acquisition of LM Wind Power’s Polish Blade Facility

Wolf Theiss, working with Gorrissen Federspiel, has advised Vestas on its acquisition of LM Wind Power Blades. DLA Piper and Plesner reportedly advised LM Wind Power.

Lambadarios Advises European Dynamics on Investment from CAPZA and Abry Partners

Lambadarios, working with Ashurst, has advised European Dynamics on an investment from CAPZA, through its Flex Equity Mid-Market 2 fund, and Abry Partners. Paul Hastings reportedly advised CAPZA. Kirkland & Ellis reportedly advised Abry Partners.